Pacer Advisors
STJ

Pacer Advisors’s St Jude Medical STJ Stock Holding History

Pacer Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,887
Closed -$472K – 1099
2016
Q4 		$472K Sell
5,887
-36
-0.6% -$2.86K 0.07% 431
2016
Q3 		$472K Buy
5,923
+545
+10% +$44K 0.07% 389
2016
Q2 		$419K Buy
5,378
+571
+12% +$40.7K 0.07% 413
2016
Q1 		$264K Buy
4,807
+447
+10% +$24.4K 0.06% 326
2015
Q4 		$269K Buy
+4,360
New +$275K 0.06% 318

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Pacer Advisors's STJ Position: Q1 2017 in Review

Pacer Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 5,887 shares — an estimated $472K sold.

Pacer Advisors first reported a position in STJ in Q4 2015 and held it in 5 quarters. The position peaked at $472K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Pacer Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Pacer Advisors sold 5,887 St Jude Medical shares in Q1 2017, an estimated $472K.
  • Pacer Advisors first reported a position in St Jude Medical in Q4 2015 and held it in 5 quarters.
  • Pacer Advisors's St Jude Medical position peaked at $472K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Pacer Advisors's 13F filing for Q1 2017, filed 9 May 2017.